Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

PREDICT: A Multicenter, Prospective, Open-Label, Clinical Study Using a New Risk Score Approach to Assess the Most Appropriate Prophylaxis Regimen to Reach Favorable Outcomes in Hemophilia A, When Switching from Standard-Half-Life Products to Damoctocog Alfa Pegol

Guy Young, Mark T Reding, Robert F. Sidonio, Jr., Doris V. Quon, Janice M. Staber, Cindy A. Leissinger, Jessica Charlet, Moncef Boukerrou

Blood (2021) 138 (Supplement 1): 2115.

https://doi.org/10.1182/blood-2021-148700

Published: 2021

Journal Articles

Longitudinal Efficacy and Safety of N8-GP for Prophylaxis and Bleed Control in US Patients

Allison P. Wheeler, Miguel A. Escobar, Susan Kearney, Janice M. Staber, Adam R. Wufsus, Vlady Ostrow, Steven R. Lentz

Blood (2021) 138 (Supplement 1): 3205.

https://doi.org/10.1182/blood-2021-147814

Published: 2021

Journal Articles

Efanesoctocog Alfa Half-Life and Clearance Are Independent of von Willebrand Factor in Severe Hemophilia A: A Post Hoc Analysis from Phase 1/2a Studies

Janice M. Staber, Toshko Lissitchkov, Barbara A. Konkle, Amy D. Shapiro, Doris V. Quon, Roshni Kulkarni, Melinda Hamilton, Ekta Seth Chhabra, Suresh Katragadda, Arman Altincatal, Annemieke Willemze, Jennifer Dumont, Margaret V. Ragni

Blood (2021) 138 (Supplement 1): 1035.

https://doi.org/10.1182/blood-2021-148534

Published: 2021

Journal Articles

Hemophilia Natural History Study (ATHN 7): Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia a and B

Tyler W. Buckner, MDMSc, Shannon L Carpenter, MD, Stacy E. Croteau, MD, Adam Cuker, MDMS, Nabil Daoud, MA, Christine L Kempton, MDMSc, Lynn M Malec, MD, Thomas W. McLean, MD, Leslie J. Raffini, MD, Janice M Staber, MD, Michael Wang, MD, Crystal Watson, BS, Ayesha Zia, MD, Michael Recht, MD PhD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-137696

Published: 2020

Journal Articles

The Discordance between Offsite to Onsite Testing for Von Willebrand Disease in Post-Menarchal Females: A Multi-Center Study

Julie Jaffray, MD, Robert F. Sidonio, Jr., MD MSc, Jemily Malvar, MS, Janice M Staber, MD, Kristina M. Haley, DO, Amy Stillings, Angela C. Weyand, MD, Sarah H. O'Brien, MD, Peter A. Kouides, MD

Blood (2019) 134 (Supplement_1): 628.

https://doi.org/10.1182/blood-2019-122379

Published: 2019

Journal Articles

Brain Anomalies in Children with Severe Factor VIII Deficiency- a Pilot Study

Ahmad Al-Huniti, MD, Lyndsay A Harshman, MD, Marci Novak, Peggy Nopoulos, MD, Janice M Staber, MD

Blood (2019) 134 (Supplement_1): 1121.

https://doi.org/10.1182/blood-2019-131804

Published: 2019

Journal Articles

Long-Term Expression of Von Willebrand Factor Via Piggybac -Mediated Gene Transfer

Blake A Johnson, Anil K. Chauhan, PhD, Janice M Staber, MD

Blood (2016) 128 (22): 3511.

https://doi.org/10.1182/blood.V128.22.3511.3511

Published: 2016

Journal Articles

Piggybac Mediated Gene Transfer To Correct Hemophilia A

Janice M Staber, MD, Molly Pollpeter, Angela Arensdorf, Patrick L Sinn, PhD, Thomas D Rutkowski, PhD, Paul B McCray, MD

Blood (2013) 122 (21): 2900.

https://doi.org/10.1182/blood.V122.21.2900.2900

Published: 2013

Journal Articles

A Gene Transfer Approach towards Hemophilia A Correction Using the Piggybac Transposon Vector.

Janice M. Staber, MD, Erin R Burnight, Pavel Korsakov, Joseph Kaminski, MD, Nancy L Craig, PhD, Paul B McCray, MD

Blood (2010) 116 (21): 1477.

https://doi.org/10.1182/blood.V116.21.1477.1477

Published: 2010

Journal Articles

Gene Transfer Targeting Hepatocytes Using the PiggyBac Transposon System: An Approach towards Hemophilia A Correction and Long Term Expression of Factor VIII.

Janice M. Staber, MD, Erin Burnight, Marie- Ellen Sarvida, MD, Anton McCaffrey, PhD, Joseph Kaminski, MD, Paul McCray, MD

Blood (2009) 114 (22): 3575.

https://doi.org/10.1182/blood.V114.22.3575.3575

Published: 2009

NARROW

PREDICT: A Multicenter, Prospective, Open-Label, Clinical Study Using a New Risk Score Approach to Assess the Most Appropriate Prophylaxis Regimen to Reach Favorable Outcomes in Hemophilia A, When Switching from Standard-Half-Life Products to Damoctocog Alfa Pegol

Longitudinal Efficacy and Safety of N8-GP for Prophylaxis and Bleed Control in US Patients

Efanesoctocog Alfa Half-Life and Clearance Are Independent of von Willebrand Factor in Severe Hemophilia A: A Post Hoc Analysis from Phase 1/2a Studies

Hemophilia Natural History Study (ATHN 7): Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia a and B

The Discordance between Offsite to Onsite Testing for Von Willebrand Disease in Post-Menarchal Females: A Multi-Center Study

Brain Anomalies in Children with Severe Factor VIII Deficiency- a Pilot Study

Long-Term Expression of Von Willebrand Factor Via Piggybac -Mediated Gene Transfer

Piggybac Mediated Gene Transfer To Correct Hemophilia A

A Gene Transfer Approach towards Hemophilia A Correction Using the Piggybac Transposon Vector.

Gene Transfer Targeting Hepatocytes Using the PiggyBac Transposon System: An Approach towards Hemophilia A Correction and Long Term Expression of Factor VIII.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only